Literature DB >> 33232843

Fusion based on attention mechanism and context constraint for multi-modal brain tumor segmentation.

Tongxue Zhou1, Stéphane Canu2, Su Ruan3.   

Abstract

This paper presents a 3D brain tumor segmentation network from multi-sequence MRI datasets based on deep learning. We propose a three-stage network: generating constraints, fusion under constraints and final segmentation. In the first stage, an initial 3D U-Net segmentation network is introduced to produce an additional context constraint for each tumor region. Under the obtained constraint, multi-sequence MRI are then fused using an attention mechanism to achieve three single tumor region segmentations. Considering the location relationship of the tumor regions, a new loss function is introduced to deal with the multiple class segmentation problem. Finally, a second 3D U-Net network is applied to combine and refine the three single prediction results. In each stage, only 8 initial filters are used, allowing to decrease significantly the number of parameters to be estimated. We evaluated our method on BraTS 2017 dataset. The results are promising in terms of dice score, hausdorff distance, and the amount of memory required for training.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Attention mechanism; Brain tumor segmentation; Context constraint; Fusion

Year:  2020        PMID: 33232843     DOI: 10.1016/j.compmedimag.2020.101811

Source DB:  PubMed          Journal:  Comput Med Imaging Graph        ISSN: 0895-6111            Impact factor:   4.790


  2 in total

Review 1.  Machine Learning Algorithms in Neuroimaging: An Overview.

Authors:  Vittorio Stumpo; Julius M Kernbach; Christiaan H B van Niftrik; Martina Sebök; Jorn Fierstra; Luca Regli; Carlo Serra; Victor E Staartjes
Journal:  Acta Neurochir Suppl       Date:  2022

2.  Research and Analysis of Brain Glioma Imaging Based on Deep Learning.

Authors:  Tao Luo; YaLing Li
Journal:  J Healthc Eng       Date:  2021-11-18       Impact factor: 3.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.